Roche Holding's cobas CMV test has been approved by the FDA for use on the fully automated cobas 6800 and cobas 8800 Systems. The real-time, PCR-based cytomegalovirus test, which can operate simultaneously with HCV or HIV-1 assays on the systems, is designed to assess response of transplant patients to treatment.
Roche's CMV test OK'd by FDA for use on cobas 6800/8800 systems
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.